Pharmacology and Toxicology was established as a department at the Georgia Health
Sciences University in 1943. The Department has a rich history of accomplishments
in fundamental research including the discovery of the adrenergic receptor subtypes-alpha
and beta- which has lead to the development of many drugs used in the treatment of
cardiovascular disease. Our research programs focus on cardiovascular studies and
The field of pharmacology originally developed as a means to discover how the age-old
remedies and poisons exert their effects on man. Pharmacology as a modern discipline
provides the groundwork for discovery and development of our future generation of
therapeutics. The scope of pharmacology has expanded greatly over the last decade
to incorporate many new approaches such as computer-assisted drug design, genetic
screens, protein engineering, and the use of novel drug delivery vehicles including
viruses and artificial cells.
Our society needs pharmacologists who understand the bases of modern therapeutics
for careers within academic, pharmaceutical and governmental laboratories to study
and develop tomorrow's drugs. Our fifteen departmental faculty members work with approximately
50 graduate students, postdoctoral fellows and staff on a variety of research areas
that include cardiac, vascular, and pulmonary diseases, and schizophrenia, learning
and memory, neuroprotection and drug abuse. Our experimental approaches range from
the gene to the whole animal level.
2013 Armand M. Karow Award
Fifth-year graduate student Paramita Pati was named the recipient of the 2013 Armand
M. Karow Award. Each year the Department of Pharmacology and Toxicology recognizes
a deserving graduate student with this distinction. The $5000 award was established
in Professor Karow’s honor through the generosity of the Karow family. Dr. Karow
joined the faculty of the Medical College of Georgia in 1968, and was Professor of
Pharmacology and Research Associate Professor of Surgery. He was given the title
of Professor Emeritus upon his retirement in 1997. Professor Karow was recognized
as one of the world’s experts in cryopreservation of transplantable cells and tissues,
and he published over 100 research articles. Dr. Karow was also the Founder and Chairman
Emeritus in Perpetuity of Xytex International, Ltd.
Ms. Pati is investigating the role of the circadian clock in hypertension under the
mentorship of Dr. R. Daniel Rudic, Associate Professor of Pharmacology and Toxicology.
Ms. Pati has presented her findings at the annual meetings of the Society for Experimental
Biology and the Society for Research on Biological Rhythms. She is also the recipient
of an American Heart Association Pre-Doctoral Fellowship. Following completion of
her dissertation and post-doctoral training, Ms. Pati looks forward to a biological
research career in academia.
Roger K. Sunahara, Ph.D.
University of Michigan Medical School
Jeffrey Johnson, Ph.D
University of Wisconsin-Madison
Chris Hague, Ph.D.
University of Washington School of Medicine
Qin Wang, MD, PhD
University of Alabama at Birmingham
Joseph Miano, Ph.D
University of Rochester Medical Center Aab Cardiovascular Research Institute Department
Julie Andersen, Ph.D
Buck Institute of Aging California
New Faculty Search